Literature DB >> 12135318

A novel missense mutation of exon 3 in the type A human natriuretic peptide receptor gene: possible association with essential hypertension.

Tomohiro Nakayama1, Masayoshi Soma, Yoshihiro Mizutani, Xu Xinjuan, Junko Honye, Yukie Kaneko, Dolkun Rahmutula, Noriko Aoi, Kotoko Kosuge, Satoshi Saito, Yukio Ozawa, Katsuo Kanmatsuse, Shinichiro Kokubun.   

Abstract

The natriuretic peptide (NP) family is involved in regulation of blood pressure and fluid volume. We recently characterized the exon/intron organization of the human type A NP receptor (hNPRA) gene. The aim of this study was to isolate the genetic markers according to the organization of this gene, and to study the association between this gene and essential hypertension. Using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) analysis, we identified a novel missense mutation, M3411, consisting of a methionine (ATG) to isoleucine (ATC) substitution at nucleotide 1023 in exon 3. Computer-aided three-dimensional structural analysis suggested that M341 exists in the loop between two alpha-helices, and that the mutation may influence receptor activities by altering the conformation of the alpha-helices. We performed an association study of the mutation in 210 essential hypertension (EH) patients and 210 normotensive controls. The overall distribution of alleles was not significantly different between the control and EH groups. However, the C/C homozygous genotype was found only in the EH group. The ratio of plasma brain natriuretic peptide (BNP)/mean blood pressure of the C/C genotype was significantly higher than that of the G/G genotype or the G/C genotype. We conclude that the significance of homozygous M3411 mutation in exon 3 is worth investigating for its possible association with EH.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12135318     DOI: 10.1291/hypres.25.395

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  7 in total

Review 1.  Genetic variation in the natriuretic peptide system and heart failure.

Authors:  David E Lanfear
Journal:  Heart Fail Rev       Date:  2008-10-11       Impact factor: 4.214

Review 2.  Pharmacogenomics of the Natriuretic Peptide System in Heart Failure.

Authors:  Ahmed Abuzaanona; David Lanfear
Journal:  Curr Heart Fail Rep       Date:  2017-12

3.  Genetic Factors Influencing B-type Natriuretic Peptide-Mediated Production of Cyclic Guanosine Monophosphate and Blood Pressure Effects in Heart Failure Patients.

Authors:  David E Lanfear; Jia Li; Raza Abbas; Ricoung She; Badri Padhukasahasram; Ramesh C Gupta; David Langholz; W H Wilson Tang; L Keoki Williams; Hani N Sabbah; Sheryl L Chow
Journal:  J Cardiovasc Transl Res       Date:  2015-11-20       Impact factor: 4.132

4.  Association study: the aminopeptidase a gene and essential hypertension.

Authors:  Morihiko Sano; Nobuhiro Kuroi; Tomohiro Nakayama; Naoyuki Sato; Yoichi Izumi; Masayoshi Soma
Journal:  Int J Biomed Sci       Date:  2005-06

5.  Haplotype Based Association Study between t-PA Gene and Essential Hypertension.

Authors:  Kosuke Saito; Tomohiro Nakayama; Naoyuki Sato; Yoshiyuki Kaneko; Ichiro Sato; Akihiko Morita; Teruyuki Takahashi; Masayoshi Soma; Ron Usami
Journal:  Int J Biomed Sci       Date:  2006-06

6.  Investigation of the association between normal-tension glaucoma and single nucleotide polymorphisms in natriuretic peptide gene.

Authors:  Jin Wook Jeoung; Dong Myung Kim; Hyun Soo Ko; Sung Sup Park; Ji Yeon Kim; Sung Yeun Kim; Tai Woo Yoo
Journal:  Korean J Ophthalmol       Date:  2007-03

7.  A novel variable number of tandem repeat of the natriuretic peptide precursor B gene's 5'-flanking region is associated with essential hypertension among Japanese females.

Authors:  Kotoko Kosuge; Masayoshi Soma; Tomohiro Nakayama; Noriko Aoi; Mikano Sato; Yoichi Izumi; Koichi Matsumoto
Journal:  Int J Med Sci       Date:  2007-05-16       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.